NYSE:IBO | Free Cash Flow | IMPACT BIOMEDICAL INC.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2022-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$464,000.00
2025-12-31$99,000.00
2025-03-31-$682,000.00
2024-12-31-$986,000.00
2024-03-31-$482,000.00
2023-12-31-$433,000.00
2023-03-31-$1.01M
2022-12-31-$363,000.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$1.89M
2024-12-31-$2.85M
2023-12-31-$2.85M
2022-12-31-$2.24M